Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Evaluation of the GeneXpert assay in the detection of Factor V Leiden and prothrombin 20210 in stored, previously classified samples.

Clinica chimica acta; international journal of clinical chemistry - 11 Apr 2012

Gessoni G, Valverde S, Manoni F

Abstract excerpt

BACKGROUND: In this study, we evaluated the GeneXpert HemosIL Factor II and Factor V assay, an innovative assay for the detection of Factor V Leiden (FVL) and prothrombin G20210A mutation (GPRO). PATIENTS AND METHODS: We evaluated 132 patients that were previously classified (with a concordant result) using two commercial real-time PCR assays supplied, by Applied Biosystems and Roche Molecular Biochemicals. The...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cohort Studies
Share to Factor V

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Mutation

Share to Prothrombin

Share to Reference Values

Source

Identifiers

PMID: 22285776
DOI: 10.1016/j.cca.2012.01.016

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Evaluation of the GeneXpert assay in the detection of Factor V Leiden and prothrombin 20210 in stored, previously classified samples.PMID 22285776Read ↗

Possible incorrect genotyping of heterozygous factor V Leiden and Prothrombin 20210 gene mutations by the GeneXpert assay.Semantic proximity Read ↗

Factor V Leiden and FII 20210 testing in thromboembolic disorders.Semantic proximity Read ↗

Genetic Testing for Thrombophilia-Related Genes: Observations of Testing Patterns for Factor V Leiden (G1691A) and Prothrombin Gene “Mutation” (G20210A)Semantic proximity Read ↗

Analytic validity of genetic tests to identify factor V Leiden and prothrombin G20210A.Semantic proximity Read ↗

Recommendations from the EGAPP Working Group: routine testing for Factor V Leiden (R506Q) and prothrombin (20210G>A) mutations in adults with a history of idiopathic venous thromboembolism and their adult family members.Semantic proximity Read ↗

Testing for Factor V Leiden (FVL) and Prothrombin G20210A Genetic Variants.Semantic proximity Read ↗

Rapid multiplex analysis for the factor V Leiden and prothrombin G20210A mutations associated with hereditary thrombophilia.Semantic proximity Read ↗

Evolving methods for single nucleotide polymorphism detection: Factor V Leiden mutation detection.Semantic proximity Read ↗

Quality in molecular biology testing for inherited thrombophilia disorders.Semantic proximity Read ↗

Clinical utility of factor V leiden (R506Q) testing for the diagnosis and management of thromboembolic disorders.Semantic proximity Read ↗

Detection of Factor V Leiden and prothrombin c.20210G>A allele by Roche Diagnostics LightCycler®.Semantic proximity Read ↗

Evaluation of the Roche diagnostics LightCycler-Factor V Leiden Mutation Detection Kit and the LightCycler-Prothrombin Mutation Detection Kit.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.